Nicotinamide riboside
- Generic Name
- Nicotinamide riboside
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H15N2O5
- CAS Number
- 1341-23-7
- Unique Ingredient Identifier
- 0I8H2M0L7N
- Background
Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).
- Associated Conditions
- -
- Associated Therapies
- -
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 45
- Registration Number
- NCT03912220
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- Douglas Seals
- Target Recruit Count
- 118
- Registration Number
- NCT03821623
- Locations
- 🇺🇸
Integrative Physiology of Aging Laboratory, Boulder, Colorado, United States
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 90
- Registration Number
- NCT03743636
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
NR in Chemo-induced Peripheral Neuropathy
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Donna Hammond, PhD
- Target Recruit Count
- 5
- Registration Number
- NCT03642990
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
🇺🇸Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
The Effects of Nicotinamide Riboside Supplementation on Brain NAD+/NADH Ratio and Bioenergetics
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT03151707
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath